|
|
| HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT BANC OF AMERICA CONFERENCE | |
|
[webcast] ROCKVILLE, Maryland – July 22, 2005 – Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that its discussion at the Banc of America New Products, New Paradigms Pharmaceuticals Conference will be webcast and may be accessed at www.hgsi.com A member of Human Genome Sciences’ senior management team will participate in a discussion of the clinical development program of LymphoStat-B for systemic lupus erythematosus (SLE) on Thursday, July 28, 2005 at 9:45 am Eastern Time. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event. Human Genome Sciences is a company with the mission to treat and cure disease by bringing new gene-based drugs to patients. HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company’s web site at www.hgsi.com.
CONTACT: |